FOXC1 and breast carcinoma: Given that FOXC1 has emerged as a specific diagnostic and prognostic biomarker for BLBC14,15 and that it induces luminal progenitor populations, overexpression of FOXC1 may cooperate with other breast cancer-associated genes or pathways to govern BLBC development.